Published in Telemedicine Law Weekly, July 21st, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Molecular Insight Pharmaceuticals, Inc.
Report 1: Molecular Insight Pharmaceuticals (NASDAQ: MIPI) announced the appointment of Norman LaFrance, M.D., to the position of Senior Vice President, Clinical Development and Chief Medical Officer. He joins Molecular Insight after a nearly 20-year industry career at DuPont-Merck, Bracco Diagnostics, Celltech, and most recently Bausch & Lomb, where he was Vice President, Global Pharmaceutical R&D.
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.